These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1016 related items for PubMed ID: 19465867
21. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC. J Am Coll Cardiol; 2008 Apr 01; 51(13):1247-54. PubMed ID: 18371553 [Abstract] [Full Text] [Related]
22. Is physician adherence to prescription guidelines a general trait of health care practices or dependent on drug type?--a multilevel logistic regression analysis in South Sweden. Ohlsson H, Merlo J. Pharmacoepidemiol Drug Saf; 2009 Aug 01; 18(8):682-90. PubMed ID: 19437457 [Abstract] [Full Text] [Related]
23. Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction. Austin PC, Tu JV, Ko DT, Alter DA. CMAJ; 2008 Oct 21; 179(9):895-900. PubMed ID: 18936454 [Abstract] [Full Text] [Related]
24. Effect of age on the use of evidence-based therapies for acute myocardial infarction. Tran CT, Laupacis A, Mamdani MM, Tu JV. Am Heart J; 2004 Nov 21; 148(5):834-41. PubMed ID: 15523314 [Abstract] [Full Text] [Related]
25. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization. Tuppin P, Neumann A, Danchin N, de Peretti C, Weill A, Ricordeau P, Allemand H. Arch Cardiovasc Dis; 2010 Nov 21; 103(6-7):363-75. PubMed ID: 20800800 [Abstract] [Full Text] [Related]
26. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Gislason GH, Rasmussen JN, Abildstrøm SZ, Gadsbøll N, Buch P, Friberg J, Rasmussen S, Køber L, Stender S, Madsen M, Torp-Pedersen C. Eur Heart J; 2006 May 21; 27(10):1153-8. PubMed ID: 16399775 [Abstract] [Full Text] [Related]
27. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey. Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M, French National College of Cardiologists. Arch Cardiovasc Dis; 2012 May 21; 105(6-7):355-65. PubMed ID: 22800720 [Abstract] [Full Text] [Related]
28. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value. Lee JH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Hong TJ, Cho MC, Kim CJ, Jun JE, Park WH, Chae SC, Korea Acute Myocardial Infarction Registry Investigators. Am Heart J; 2010 Jun 21; 159(6):1012-9. PubMed ID: 20569714 [Abstract] [Full Text] [Related]
29. Use of secondary preventive medications after the first attack of acute coronary syndrome. Salomaa V, Pääkkönen R, Hämäläinen H, Niemi M, Klaukka T. Eur J Cardiovasc Prev Rehabil; 2007 Jun 21; 14(3):386-91. PubMed ID: 17568237 [Abstract] [Full Text] [Related]
30. Association of early follow-up after acute myocardial infarction with higher rates of medication use. Daugherty SL, Ho PM, Spertus JA, Jones PG, Bach RG, Krumholz HM, Peterson ED, Rumsfeld JS, Masoudi FA. Arch Intern Med; 2008 Mar 10; 168(5):485-91; discussion 492. PubMed ID: 18332293 [Abstract] [Full Text] [Related]
31. [Management of acute myocardial infarction in the experience of a community hospital. A prospective study]. Tincani E, Mazzoli V, Bondi M. Minerva Cardioangiol; 1997 Mar 10; 45(7-8):335-47. PubMed ID: 9463169 [Abstract] [Full Text] [Related]
32. The management of acute myocardial infarction--practical problems in implementing the evidence. O'Neill JO, Nash PJ, Bourke W, McGarry K, Bedford D. Ir Med J; 2002 Oct 10; 95(9):270-2. PubMed ID: 12469997 [Abstract] [Full Text] [Related]
33. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry. Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP, REACH Investigators. Crit Pathw Cardiol; 2009 Sep 10; 8(3):104-11. PubMed ID: 19726929 [Abstract] [Full Text] [Related]
34. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline. Peters-Klimm F, Müller-Tasch T, Remppis A, Szecsenyi J, Schellberg D. J Eval Clin Pract; 2008 Oct 10; 14(5):823-9. PubMed ID: 19018915 [Abstract] [Full Text] [Related]
35. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community. Granmyr J, Ball P, Curran S, Wang L. Aust J Rural Health; 2007 Aug 10; 15(4):241-6. PubMed ID: 17617087 [Abstract] [Full Text] [Related]
36. Clinical impact of local implementation of agreed guidelines for the management of patients with acute myocardial infarction. Badano L, Cassin M, Solinas L, Burelli C, Macor F, Zanuttini D. G Ital Cardiol; 1999 Jan 10; 29(1):39-47. PubMed ID: 9987046 [Abstract] [Full Text] [Related]
37. An evaluation of the relationship between specialist training in cardiology and implementation of evidence-based care of patients following acute myocardial infarction. Dorsch MF, Lawrance RA, Sapsford RJ, Durham N, Das R, Jackson BM, Morrell C, Ball SG, Robinson MB, Hall AS, EMMACE (Evaluation of Methods and Management of Acute Coronary Events) Study Group. Int J Cardiol; 2004 Sep 10; 96(3):335-40. PubMed ID: 15301884 [Abstract] [Full Text] [Related]
38. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000. Al Khaja KA, Sequeira RP. Pharmacoepidemiol Drug Saf; 2006 Oct 10; 15(10):741-8. PubMed ID: 16342299 [Abstract] [Full Text] [Related]
39. Use of evidence-based therapy for the prevention of cardiovascular events among older people. Castelino RL, Chen TF, Guddattu V, Bajorek BV. Eval Health Prof; 2010 Sep 10; 33(3):276-301. PubMed ID: 20801973 [Abstract] [Full Text] [Related]
40. [Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?]. Böger GI, Hoopmann M, Busse R, Budinger M, Welte T, Böger RH. Z Kardiol; 2003 Jun 10; 92(6):466-75. PubMed ID: 12819995 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]